Envoy Medical, Inc. (COCH)
(Delayed Data from NSDQ)
$1.43 USD
-0.02 (-1.04%)
Updated Aug 4, 2025 03:57 PM ET
After-Market: $1.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COCH 1.43 -0.02(-1.04%)
Will COCH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COCH
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates
COCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orthofix (OFIX) Q3 Earnings Surpass Estimates
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Other News for COCH
Envoy Medical GAAP EPS of -$0.32, revenue of $0.08M
Envoy Medical Reports on Second Quarter 2025 Results | COCH Stock News
Envoy Medical Expands Patent Portfolio with New Issuances in the United States | COCH Stock News
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia | COCH Stock News
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, ...